SCAI Issues Expert Consensus for Treating Patients With Cancer, Concomitant Heart Disease

medical news

The paper aims to increase the competency of cardiovascular professionals providing care to cancer patients.
“Little data exists as patients with cancer have been excluded from national percutaneous coronary interventions [PCI] registries and from most randomised trials involving PCI,” said lead author Cezar A. Iliescu, MD, Cardiac Catheterization Laboratory, University of Texas M. D. Anderson Cancer Center, Houston, Texas. “Therefore, SCAI commissioned a consensus group to define the landscape and provide recommendations based on the available published medical literature and the expertise of operators with accumulated experience in the cardiac catheterisation of cancer patients.”
Cancer is associated with a hypercoagulable state which increases the risk of acute thrombotic events. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes, arrhythmias and heart failure, even independently from a direct myocardial effect......